Adverse haematological effects of vinblastine, prednisolone and cimetidine treatment: A retrospective study in fourteen dogs with mast cell tumours

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 52, Issue 6, 2005, Pages 275-279

  Trumel, C ^a   Bourges Abella N ^a   Touron, C ^a   Lanore, D ^a,b   Geffre A ^a   Diquelou, A ^a,c   Guelfi, J F ^a   Braun, J P ^a,c  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b CLINIQUE VÉTÉRINAIRE   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CIMETIDINE; IMMUNOLOGICAL ADJUVANT; PREDNISOLONE; VINBLASTINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD CELL; DOG; DOG DISEASE; DRUG EFFECT; FEMALE; MALE; RETROSPECTIVE STUDY; SARCOMA; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOOD CELLS; CIMETIDINE; DOG DISEASES; DOGS; FEMALE; MALE; MAST-CELL SARCOMA; PREDNISOLONE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VINBLASTINE;

EID: 26044436253     PISSN: 0931184X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0442.2005.00725.x     Document Type: Article

References (25)

1. Abadie, J., M. Amardeilh, and M. Delverdier, 1999: Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs. J. Am. Vet. Med. Assoc. 215, 1629-1634.
2. Boggs, D. R., J. W. Athens, O. P. Haab, P. A. Cancilla, S. O. Raab, G. A. Cartwright, and M. M. Wintrobe, 1963: Leukokinetics studies. VII. Morphology of the bone marrow and blood of dogs given vinblastine sulphate. Blood 23, 53-67.
3. Boggs, D. R., J. W. Athens, G. A. Cartwright, and M. M. Wintrobe, 1966a: The different effects of vinblastine sulphate and nitrogen mustard upon neutrophil kinetics in the dog. Proc. Soc. Exp. Biol. Med. 121, 1085-1090.
4. Boggs, D. R., G. A. Cartwright, and M. M. Wintrobe, 1966b: Neutrophilia-inducing activity in plasma of dogs recovering from drug-induced myelotoxicity. Am. J. Physiol. 211, 51-60.
5. Brooks, M. B., R. E. Matus, C. E. Leifer, A. A. Alfieri, and A. K. Patnaik, 1988: Chemotherapy versus chemotherapy plus radiotherapy in the treatment of tonsillar squamous cell carcinoma in the dog. J. Vet. Intern. Med. 2, 206-211.
6. Creasey, W. A., I. A. Scott, C. C. Wei, J. Kutcher, A. Schwartz, and J. C. Marsh, 1975: Pharmacological studies with vinblastine in the dog. Cancer Res. 35, 1116-1120.
7. Crow, S. E., 1977: Treatment of a mast cell tumor in a dog. Mod. Vet. Pract. 58, 766-767.
8. Davies, R. D., K. M. Wyatt, J. E. Jardine, I. D. Robertson, and P. J. Irwin, 2004: Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors. J. Am. Anim. Hosp. Assoc. 40, 124-130.
9. Golden, D. L., and V. C. Langston, 1988: Uses of vincristine and vinblastine in dogs and cats. J. Am. Vet. Med. Assoc. 193, 1114-1117.
10. Hahn, K. A., G. K. King, and J. K. Carreras, 2004: Efficacy of radiation theraphy for incompletely resected grade-III mast cell tumors in dogs: 31 cases (1987-1998). J. Am. Vet. Med. Assoc. 224, 79-82.
11. Harker, W. G., J. H. Ward, and J. R. Stewart, 1993: Principles of therapy and effects of specific drugs in the treatment of neoplastic diseases of the hematopoietic system. In: Lee, G. R., T. C., Bithell, J., Foerster, J. W., Athens, J. N., Lukens (eds), Wintrobe's Clinical Haematology, 9th edn. pp. 1843-1872. Lea & Febiger, Philadelphia.
12. Henness, A. M., and S. E. Crow, 1977: Treatment of feline myelogenous leukaemia: four case reports. J. Am. Vet. Med. Assoc. 171, 263-266.
13. Kitchell, B. E., and R. S. Dhaliwal, 2000: CVT update: anticancer drugs and protocols using traditional drugs. In: Bonagura, J. D. (ed.), Kirk's Current Veterinary Therapy. XIII: Small Animal Practice, pp. 465-473. W. B. Saunders Company, Philadelphia.
14. Lanore, D., and C. Delprat, 2002: Chimiothérapie anticancéreuse. Masson-AFVAC, Paris.
15. Murphy, S., A. H. Sparkes, K. C. Smith, A. S. Blunden, and M. J. Brearley, 2004: Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection. Vet. Rec. 154, 743-746.
16. Patnaik, A. K., W. J. Ehler, and E. G. MacEwen, 1984: Canine cutaneous mast cell tumors: morphologic grading and survival time in 83 dogs. Vet. Pathol. 21, 469-474.
17. Plumb, D. C., 2002: Veterinary Drug Handbook, 4th edn. Iowa State Press, Ames, IA.
18. Rassnick, K. M., A. S. Moore, L. E. Williams, C. A. London, P. P. Kintzer, S. J. Engler, and S. M. Cotter, 1999: Treatment of canine mast cell tumors with CCNU (lomustine). J. Vet. Intern. Med. 13, 601-605.
19. Rosenthal, R. C., 1981: Clinical applications of vinca alkaloids. J. Am. Vet. Med. Assoc. 179, 1084-1086.
20. Séguin, B., N. F. Leibman, V. S. Bregazzi, G. K. Ogilvie, B. E. Powers, W. S. Dernell, M. J. Fettman, and S. J. Withrow, 2001: Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999). J. Am. Vet. Med. Assoc. 218, 1120-1123.
21. Simpson, A. M., L. L. Ludwig, S. J. Newman, P. J. Bergman, H. A. Hottinger, and A. K. Patnaik, 2004: Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs. J. Am. Vet. Med. Assoc. 224, 236-240.
22. Singh, J., J. S. Rana, N. Sood, G. R. Pangawkar, and P. P. Gupta, 1996: Clinico-pathological studies on the effect of different anti-neoplastic chemotherapy regimens on transmissible venereal tumours in dogs. Vet. Res. Commun. 20, 71-81.
23. Thamm, D. H., E. A. Mauldin, and D. M. Vail, 1999: Prednisone and vinblastine chemotherapy for canine mast cell tumor- 41 cases (1992-1997). J. Vet. Intern. Med. 13, 491-497.
24. Wasecki, A., and O. Mazur, 1977: Use of vinblastine in the treatment of Sticker's transmissible venereal tumours. Medycyna Wet. 33, 142-143.
25. Yamaoka, A., S. Hashimoto, S. Furukawa, S. Saegusa, and H. Yamamura, 2002: Combination chemotherapy on primary lung adenocarcinoma in an old dog. J. Jpn. Vet. Med. Assoc. 55, 679-682.